Global Protein Engineering Market 2018-2022
About Protein Engineering
Protein engineering involves introducing changes to the structure of proteins to create new proteins.
Technavio’s analysts forecast the global protein engineering market to grow at a CAGR of 15.55% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global protein engineering market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Protein Engineering Market 2018-2022
Technavio recognizes the following companies as the key players in the global protein engineering market: Agilent Technologies, Genscript, Intrexon, Lonza, Perkin Elmer, and Thermo Fisher.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is application of protein engineering in enzyme technology. The increasing application of protein engineering in enzyme technology is gaining traction in the market. Various industries involving processes such as pulp bleaching require enzymes with robust activity at high pH and temperatures.”
According to the report, one driver in the market is increasing incidences of diseases to rise demand for novel protein therapeutics. There have been growing incidences of chronic diseases leading to the rising novel therapeutics. Several protein engineering products including the monoclonal antibodies often provide therapeutic remedies for ailments such as genetic disorders, cancer, and autoimmune diseases.
Further, the report states that one challenge in the market is lack of trained laboratory professionals. Processes involved in protein engineering require accurate interpretation of results and researchers must know to interpret experimental results and correlate with the hypothesis of the experiment.
Agilent Technologies, Genscript, Intrexon, Lonza, Perkin Elmer, and Thermo Fisher.